Erratum: Liver grafts for transplantation from donors with diabetes: An analysis of the scientific registry of transplant recipients database (PLoS ONE (2014) 9, 5, (e98104) DOI:10.1371/journal.pone.0098104);Liver grafts for transplantation from donors with diabetes: An analysis of the scientific registry of transplant recipients database

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Zheng, Jun ^a,b   Xiang, Jie ^a   Zhou, Jie ^a   Li, Zhiwei ^a   Hu, Zhenhua ^a   Lo, Chung Mau ^b   Wang, Weilin ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HUMAN; LIVER DISEASE; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; AGED; COHORT ANALYSIS; DONOR; KAPLAN MEIER METHOD; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; REGISTER; TIME; TRANSPLANTATION; TREATMENT OUTCOME; UNITED STATES; VIROLOGY;

ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS; FEMALE; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME; UNITED STATES;

EID: 84901292762     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106226     Document Type: Erratum

References (20)

1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, et al. (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378: 31-40.
2. Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94: 311-321.
3. Samuelson AL, Lee M, Kamal A, Keeffe EB, Ahmed A (2010) Diabetes mellitus increases the risk of mortality following liver transplantation independent of MELD score. Dig Dis Sci 55: 2089-2094.
4. Kim WR, Stock PG, Smith JM, Heimbach JK, Skeans MA, et al. (2013) OPTN/SRTR 2011 Annual Data Report: liver. Am J Transplant 13 Suppl 1: 73-102.
5. Narayanan Menon KV, Nyberg SL, Harmsen WS, DeSouza NF, Rosen CB, et al. (2004) MELD and other factors associated with survival after liver transplantation. Am J Transplant 4: 819-825. (Pubitemid 38637583)
6. John PR, Thuluvath PJ (2001) Outcome of liver transplantation in patients with diabetes mellitus: a case-control study. Hepatology 34: 889-895. (Pubitemid 33032023)
7. Wahlstrom HE, Cooper J, Gores G, Rosen C, Wiesner R, et al. (1991) Survival after liver transplantation in diabetics. Transplant Proc 23: 1565-1566.
8. Nair S, Verma S, Thuluvath PJ (2002) Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 35: 105-109. (Pubitemid 34032549)
9. Levine GN, McCullough KP, Rodgers AM, Dickinson DM, Ashby VB, et al. (2006) Analytical methods and database design: implications for transplant researchers, 2005. Am J Transplant 6: 1228-1242.
10. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, et al. (2006) Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 6: 783-790. (Pubitemid 43345017)
11. Blanco JJ, Herrero JI, Quiroga J, Sangro B, Gomez-Manero N, et al. (2001) Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events. Liver Transpl 7: 226-233. (Pubitemid 32243818)
12. Shields PL, Tang H, Neuberger JM, Gunson BK, McMaster P, et al. (1999) Poor outcome in patients with diabetes mellitus undergoing liver transplantation. Transplantation 68: 530-535. (Pubitemid 29416629)
13. Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Jarvinen H (2008) Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology 135: 122-130. (Pubitemid 351899009)
14. Hossain N, Afendy A, Stepanova M, Nader F, Srishord M, et al. (2009) Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 7: 1224-1229, 1229 e1221-1222.
15. Angulo P, Keach JC, Batts KP, Lindor KD (1999) Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30: 1356-1362.
16. Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43: S99-S112.
17. Nocito A, El-Badry AM, Clavien PA (2006) When is steatosis too much for transplantation? J Hepatol 45: 494-499. (Pubitemid 44307398)
18. Briceno J, Ciria R, Pleguezuelo M, Naranjo A, Sanchez-Hidalgo J, et al. (2007) Contribution of marginal donors to liver transplantation for hepatitis C virus infection. Transplant Proc 39: 2297-2299. (Pubitemid 47418216)
19. Nadig SN, Bratton CF, Karp SJ (2007) Marginal donors in liver transplantation: expanding the donor pool. J Surg Educ 64: 46-50.
20. Busuttil RW, Tanaka K (2003) The utility of marginal donors in liver transplantation. Liver Transpl 9: 651-663. (Pubitemid 36874450)